Ukraine seeks to reclaim its role as a clinical trials hub

Researchers and executives are increasingly urging companies to restart trials, insisting the war is an obstacle that can be surmounted.

February 22, 2024 Check out STAT+

Sponsored By

Roman Minchyn/Wikimedia Commons War zone or not, Ukraine seeks to reclaim its role as a hub for clinical trials Researchers and executives are increasingly urging companies to restart clinical trials, insisting that the war is an obstacle that can be surmounted. By Andrew Joseph Presidential age debate obscures a simple fact: Some cognitive skills improve as we get older Researchers say some mental skills improve with age. Older adults are better at decision-making, navigating conflict, managing stress. By Olivia Goldhill Florida policy set amid measles outbreak alarms vaccination proponents The state department of health is allowing parents to decide whether to send unvaccinated children to a school that has an outbreak. By Helen Branswell Sandy Huffaker/Getty Images Opinion: The Alabama IVF ruling uses faux scientific language to justify a religious position Cryogenic nursery? Extrauterine children? The language of the Alabama ruling undermining IVF invents new terms. By David Sable STAT+ | Novavax and Gavi end a bitter dispute over Covid-19 vaccines with a refund up to $475 million Initially, Gavi sought $700 million in payments that were made to Novavax for vaccines that were never delivered. By Ed Silverman STAT+ | DOJ investigating Community Health Systems' hospitals Hospital chain Community Health Systems is facing a new federal probe into its hospital billing practices. By Bob Herman Adobe Opinion: How to make after-hours primary care better for doctors — and patients Patients deserve an on-call team that is ready to address their concerns whenever they arise, and clinicians deserve the opportunity to rest. By Jeffrey Millstein and Jeffrey Tokazewski STAT+ | San Diego biotech Neurocrine Biosciences joins PhRMA The company is the second to join PhRMA since the passage of the Inflation Reduction Act as the lobbying group rebuilds its membership By Rachel Cohrs

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser